Testing glibenclamide for nerve pain in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy, Pain clinical trials.
This study tests if glibenclamide, a drug already used for diabetes, can reduce nerve-related pain in people with multiple sclerosis. It aims to find a new treatment option for this type of pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with multiple sclerosis using standard criteria.
- You have a certain level of nerve pain, as measured by a pain questionnaire.
- You do not have severe kidney or liver problems.
- You do not have certain heart conditions or recent heart events.
- You do not have diabetes treated with insulin or oral medication.
- You are not allergic to sulfa drugs or sulfonylurea medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a GLP-1 receptor agonist can help people with multiple sclerosis who have a high BMI. It may reduce inflammation and improve health.
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
This study tests whether a new medication called Crisugabalin can reduce nerve pain in people with NMOSD. It's a 4-week trial where you could receive the study drug or a placebo (a dummy pill) — neither you nor your doctor will know which one you get.
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
This study tests a new drug (HL-1186) for diabetic nerve pain. It aims to see if it reduces pain safely in people with type 1 or type 2 diabetes who have had nerve pain for at least 6 months.
This trial tests if adding DLBS1033 to standard treatment can help people with diabetic neuropathy, a nerve condition causing pain or numbness from diabetes. It aims to see if it improves nerve symptoms and quality of life.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.